Singapore markets closed

Eton Pharmaceuticals, Inc. (ETON)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.7500-0.0500 (-1.32%)
At close: 04:00PM EDT
3.8100 +0.06 (+1.60%)
After hours: 05:30PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
31,642
31,642
21,251
21,832
39
Cost of revenue
10,581
10,581
6,933
2,827
436
Gross profit
21,061
21,061
14,318
19,005
-397
Operating expenses
Research development
3,322
3,322
3,996
6,235
14,104
Selling general and administrative
18,931
18,931
18,582
14,265
12,610
Total operating expenses
22,253
22,253
22,578
20,500
26,714
Operating income or loss
-1,192
-1,192
-8,260
-1,495
-27,111
Total other income/expenses net
-
-
-
546
-
Income before tax
-689
-689
-9,021
-1,955
-27,970
Income tax expense
247
247
0
0
0
Income from continuing operations
-936
-936
-9,021
-1,955
-27,970
Net income
-936
-936
-9,021
-1,955
-27,970
Net income available to common shareholders
-936
-936
-9,021
-1,955
-27,970
Basic EPS
0.09
-
-0.36
-0.08
-1.33
Diluted EPS
0.09
-
-0.36
-0.08
-1.33
Basic average shares
25,556
-
25,146
25,207
21,010
Diluted average shares
25,848
-
25,146
25,207
21,010